National Drug Strategy
National Drug Strategy

Australia's National Drug Strategy beyond 2009: consultation paper

Performance measures

prev pageTOC |next page

A key aspect of Australia's drug approach has been the commitment to a comprehensive evidence base to inform and guide policy and program development. Australia has sophisticated data sources that enable us to identify trends in licit and illicit drug use and monitor efforts to address their use. This information also assists in the ongoing development of targeted programs and law enforcement and border protection activities to most effectively minimise the demand, supply and harms from drugs.

Data collection and reporting on drug issues needs continual attention and improvement. In addition, it may be desirable to develop a small number of high level, publicly reported performance measures under the National Drug Strategy to help improve transparency and accountability against the Strategy’s objectives.

Are publicly available performance measures against the National Drug Strategy desirable?

If so, what measures would give a high level indication of progress under the National Drug Strategy?

prev pageTOC |next page